Загрузка...
Benefits of introduction of Oncotype DX(®) testing
INTRODUCTION: Decisions regarding adjuvant chemotherapy in women with oestrogen receptor positive, human epidermal growth factor receptor 2 negative, node negative, early invasive breast cancer are unclear. The Recurrence Score(®) (RS) from Oncotype DX(®) (ODX) testing guides decisions based on indi...
Сохранить в:
| Опубликовано в: : | Ann R Coll Surg Engl |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Royal College of Surgeons
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6303812/ https://ncbi.nlm.nih.gov/pubmed/30322288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1308/rcsann.2018.0173 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|